Elizabeth A Pyatak1, Kristine Carandang2, Cheryl Vigen2, Jeanine Blanchard2, Paola A Sequeira3, Jamie R Wood4, Donna Spruijt-Metz5, Robin Whittemore6, Anne L Peters7. 1. Division of Occupational Science and Occupational Therapy, University of Southern California, 1540 Alcazar St., CHP-133, Los Angeles, USA. Electronic address: Beth.pyatak@chan.usc.edu. 2. Division of Occupational Science and Occupational Therapy, University of Southern California, 1540 Alcazar St., CHP-133, Los Angeles, USA. 3. Department of Pediatrics, University of Southern California, 2020 Zonal Ave, Rm. 115, Los Angeles, CA 90033, USA. 4. Department of Pediatrics, University of Southern California, 2020 Zonal Ave, Rm. 115, Los Angeles, CA 90033, USA; Children's Hospital Los Angeles, 4650 Sunset Boulevard, MS # 61, Los Angeles, CA 90027, USA. 5. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, MC 9239, Los Angeles, CA 90089, USA. 6. Yale School of Nursing, 100 Church Street South, P.O. Box 9740, New Haven, CT 06536-0740, USA. 7. Division of Endocrinology, University of Southern California, 9033 Wilshire Blvd. Suite 406, Beverly Hills, CA 90211, USA.
Abstract
OVERVIEW: This paper describes the study protocol used to evaluate the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) intervention and reports on baseline characteristics of recruited participants. REAL Diabetes is an activity-based intervention designed to address the needs of young adults diagnosed with type 1 (T1D) or type 2 diabetes (T2D) from low socioeconomic status or racial/ethnic minority backgrounds. The REAL intervention incorporates tailored delivery of seven content modules addressing various dimensions of health and well-being as they relate to diabetes, delivered by a licensed occupational therapist. METHODS: In this pilot randomized controlled trial, participants are assigned to the REAL Diabetes intervention or an attention control condition. The study's primary recruitment strategies included in-person recruitment at diabetes clinics, mass mailings to clinic patients, and social media advertising. Data collection includes baseline and 6-month assessments of primary outcomes, secondary outcomes, and hypothesized mediators of intervention effects, as well as ongoing process evaluation assessment to ensure study protocol adherence and intervention fidelity. RESULTS: At baseline, participants (n=81) were 51% female, 78% Latino, and on average 22.6years old with an average HbA1c of 10.8%. A majority of participants (61.7%) demonstrated clinically significant diabetes distress and 27.2% reported symptoms consistent with major depressive disorder. Compared to participants with T1D, participants with T2D had lower diabetes-related self-efficacy and problem-solving skills. Compared to participants recruited at clinics, participants recruited through other strategies had greater diabetes knowledge but weaker medication adherence. DISCUSSION: Participants in the REAL study demonstrate clinically significant medical and psychosocial needs.
RCT Entities:
OVERVIEW: This paper describes the study protocol used to evaluate the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) intervention and reports on baseline characteristics of recruited participants. REAL Diabetes is an activity-based intervention designed to address the needs of young adults diagnosed with type 1 (T1D) or type 2 diabetes (T2D) from low socioeconomic status or racial/ethnic minority backgrounds. The REAL intervention incorporates tailored delivery of seven content modules addressing various dimensions of health and well-being as they relate to diabetes, delivered by a licensed occupational therapist. METHODS: In this pilot randomized controlled trial, participants are assigned to the REAL Diabetes intervention or an attention control condition. The study's primary recruitment strategies included in-person recruitment at diabetes clinics, mass mailings to clinic patients, and social media advertising. Data collection includes baseline and 6-month assessments of primary outcomes, secondary outcomes, and hypothesized mediators of intervention effects, as well as ongoing process evaluation assessment to ensure study protocol adherence and intervention fidelity. RESULTS: At baseline, participants (n=81) were 51% female, 78% Latino, and on average 22.6years old with an average HbA1c of 10.8%. A majority of participants (61.7%) demonstrated clinically significant diabetes distress and 27.2% reported symptoms consistent with major depressive disorder. Compared to participants with T1D, participants with T2D had lower diabetes-related self-efficacy and problem-solving skills. Compared to participants recruited at clinics, participants recruited through other strategies had greater diabetes knowledge but weaker medication adherence. DISCUSSION: Participants in the REAL study demonstrate clinically significant medical and psychosocial needs.
Authors: F Clark; S P Azen; M Carlson; D Mandel; L LaBree; J Hay; R Zemke; J Jackson; L Lipson Journal: J Gerontol B Psychol Sci Soc Sci Date: 2001-01 Impact factor: 4.077
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Katharine S Steinbeck; Vanessa A Shrewsbury; Vanessa Harvey; Kara Mikler; Kim C Donaghue; Maria E Craig; Helen J Woodhead Journal: Pediatr Diabetes Date: 2014-11-11 Impact factor: 4.866
Authors: Florence Clark; Elizabeth A Pyatak; Mike Carlson; Erna Imperatore Blanche; Cheryl Vigen; Joel Hay; Trudy Mallinson; Jeanine Blanchard; Jennifer B Unger; Susan L Garber; Jesus Diaz; Lucia I Florindez; Michal Atkins; Salah Rubayi; Stanley Paul Azen Journal: Clin Trials Date: 2014-02-26 Impact factor: 2.486
Authors: Electra D Paskett; Katherine W Reeves; John M McLaughlin; Mira L Katz; Ann Scheck McAlearney; Mack T Ruffin; Chanita Hughes Halbert; Cristina Merete; Faith Davis; Sarah Gehlert Journal: Contemp Clin Trials Date: 2008-07-31 Impact factor: 2.226
Authors: Florence Clark; Jeanne Jackson; Mike Carlson; Chih-Ping Chou; Barbara J Cherry; Maryalice Jordan-Marsh; Bob G Knight; Deborah Mandel; Jeanine Blanchard; Douglas A Granger; Rand R Wilcox; Mei Ying Lai; Brett White; Joel Hay; Claudia Lam; Abbey Marterella; Stanley P Azen Journal: J Epidemiol Community Health Date: 2011-06-02 Impact factor: 3.710
Authors: Elizabeth A Pyatak; Kristine Carandang; Cheryl L P Vigen; Jeanine Blanchard; Jesus Diaz; Alyssa Concha-Chavez; Paola A Sequeira; Jamie R Wood; Robin Whittemore; Donna Spruijt-Metz; Anne L Peters Journal: Diabetes Care Date: 2018-01-19 Impact factor: 19.112
Authors: Daniella Meeker; Paul Fu; Gary Garcia; Irene E Dyer; Kabir Yadav; Ross Fleishman; Hal F Yee Journal: J Am Med Inform Assoc Date: 2022-03-15 Impact factor: 4.497
Authors: Cheryl L P Vigen; Kristine Carandang; Jeanine Blanchard; Paola A Sequeira; Jamie R Wood; Donna Spruijt-Metz; Robin Whittemore; Anne L Peters; Elizabeth A Pyatak Journal: Diabetes Educ Date: 2018-10-08 Impact factor: 2.140
Authors: Sandrine Luce; Sophie Guinoiseau; Alexis Gadault; Franck Letourneur; Patrick Nitschke; Marc Bras; Michel Vidaud; Pierre Charneau; Etienne Larger; Maikel L Colli; Decio L Eizirik; François Lemonnier; Christian Boitard Journal: Front Immunol Date: 2021-10-14 Impact factor: 7.561